content

LDC and SOTIO Enter License and Collaboration Agreement for First-in-class Cancer Metabolism Program

The Lead Discovery Center GmbH (LDC), Max Planck Innovation GmbH (MI) and SOTIO a.s. have signed a collaboration and license agreement providing SOTIO with...

Neurocrine Announces FDA Approval of INGREZZA TM ย Capsulesย 

Neurocrine Biosciences, Inc. announced that the U.S. FDA hasย approved INGREZZATM (valbenazine) capsules for the treatment of adults with tardive dyskinesia (TD). ...

DiscoverX Partners with Bโ€™SYS GmbH to Expand SAFETYscan In Vitro Pharmacological Profiling Services

DiscoverX Corporation, the leading supplier of innovative cell-based assays and services for drug discovery and developmentย announced their partnership with Bโ€™SYS GmbH to expand DiscoverXโ€™s...

Eyevensys receives French regulatory approval to advance EyeCET platform

Eyevensys, a private biotechnology company developing its proprietary EyeCET platform, the first non-viral gene expression technology that enables the safe, local, sustained production of...

Inovio Ebola Vaccine Demonstrates Robust Immune Responses with Favorable Safety Profile in Expanded Clinical Trial

Inovio Pharmaceuticals, Inc. announced preliminary results from the expanded stage of its phase I study, EBOV-001. The expanded study examined different regimens of its...

Cytori Receives FDA Approval for Burn Clinical Trial Related to BARDA Contract

Cytori Therapeutics, Inc. announced that the U.S. FDA has approved an IDE for a pilot clinical trial to evaluate Cytori Cell Therapyโ„ข in patients...

Industry 4.0 from Bosch: a new level of efficiency Digital and virtual support facilitate work processesย 

At interpack 2017, Bosch Packaging Technology shows how industry 4.0 solutions provide higher efficiency in modern manufacturing. โ€œAll of our industry 4.0 applications focus...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read